Recent synthetic efforts in the preparation of 2- (3,4)-alkenyl (aryl) quinoline molecules towards anti-kinetoplastid agents

dc.contributor.authorOrozco, Dayana.
dc.contributor.authorKouznetsov, Vladimir V.
dc.contributor.authorBermudez, Armando.
dc.contributor.authorVargas Mendez, Leonor Y.
dc.contributor.authorMendoza Salgado, Arturo Rene.
dc.contributor.authorMelendez Gómez, Carlos Mario.
dc.contributor.cvlachttp://scienti.colciencias.gov.co:8081/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0000009989
dc.contributor.cvlachttp://scienti.colciencias.gov.co:8081/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0000158623
dc.contributor.cvlachttps://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0001684855
dc.contributor.cvlachttps://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0000254410
dc.contributor.googlescholarhttps://scholar.google.com/citations?user=fzEpM-4AAAAJ&hl=en
dc.contributor.googlescholarhttps://scholar.google.es/citations?user=qj7XoWUAAAAJ&hl=es
dc.contributor.orcidhttps://orcid.org/0000-0003-1417-8355
dc.contributor.orcidhttps://orcid.org/0000-0003-4149-6623
dc.date.accessioned2020-05-27T12:35:18Z
dc.date.available2020-05-27T12:35:18Z
dc.date.issued2020-05-26
dc.description.abstractLeishmaniasis, Chagas disease and African sleeping sickness have been considered some of the most important tropical protozoan afflictions. As the number of drugs currently available to treat these human illnesses is severely limited and the majority has poor safety profiles and complicated administration schedules, actually there is an urgent need to develop new effective, safe and cost-effective drugs. Because quinoline alkaloids with antiprotozoal activity (quinine, chimanine, cryptolepine or huperzine groups) were historically and are still essential models for drug research to combat these parasitic infections, synthetic or semi-synthetic quinoline-based molecules are important for anti-kinetoplastid drug design approaches and synthetic methods of their preparation become a key task that is the central subject of this review. Its goal is to highlight the advances in the conventional and current syntheses of new 2-(3,4)-alkenyl (aryl) quinoline derivatives, which kill the most important kinetoplastid protozoa, – Leishmania and Trypanosoma and could be useful models for antileishmanial and antitrypanosomal research. An attempt has been made to present and discuss the more recent contributions in this field over the period 2015–2019, paying special attention to molecular design, synthetic efforts to new green reaction conditions for classical methods such as Skraup synthesis, Friedlander synthesis, Conrad ¨ – Limpach, Doebner–Miller, as well as contemporary methods like Gould–Jacobs, Meth–Cohn and Povarov reactions. This review includes brief general information on these neglected tropical diseases, their current chemotherapies, and primary natural models (quinoline alkaloids), suitable for development of anti-kinetoplastid quinoline-based agents. The main part of the review comprises critical discussion on the synthesis and chemistry of new quinolines diversely substituted by alkyl (alkenyl, aryl) fragments on the pyridine part of the quinoline skeleton, which could be considered interesting analogues of chimanine alkaloids. The methods described in this review were developed with the aim of overcoming the drawbacks of the traditional protocols using revolutionary precursors and strategies.spa
dc.description.domainhttp://unidadinvestigacion.usta.edu.cospa
dc.format.mimetypeapplication/pdf
dc.identifier.citationOrozco, D., Kouznetsov, V. V., Bermúdez, A., Vargas Méndez, L. Y., Mendoza Salgado, A. R., & Meléndez Gómez, C. M. (2020). Recent synthetic efforts in the preparation of 2-(3,4)-alkenyl (aryl) quinoline molecules towards anti-kinetoplastid agents. RSC Advances, 10(9), 4876-4898. https://doi.org/10.1039/C9RA09905Kspa
dc.identifier.doihttps://doi.org/10.1039/C9RA09905Kspa
dc.identifier.urihttp://hdl.handle.net/11634/23481
dc.publisher.branchCRAI-USTA Bogotáspa
dc.relation.referencesM. Njoroge, N. M. Njuguna, P. Mutai, D. S. Ongarora, P. W. Smith and K. Chibale, Chem. Rev., 2014, 114, 11138– 11163.spa
dc.relation.referencesP. M. Njogu and K. Chibale, Curr. Med. Chem., 2013, 20, 1715–1742.spa
dc.relation.referencesA. Kryshchyshyn, D. Kaminskyy, P. Grellier and R. Lesyk, Eur. J. Med. Chem., 2014, 85, 51–64.spa
dc.relation.referencesS. Vandekerckhove and M. D’hooghe, Bioorg. Med. Chem., 2015, 23, 5098–5119.spa
dc.relation.referencesP. Y. Chung, Z. X. Bian, H. Y. Pun, D. Chan, A. S. Chan, C. H. Chui, J. T. Tang and K. H. Lam, Future Med. Chem., 2015, 7, 947–967.spa
dc.relation.referencesV. V. Kouznetsov, L. Y. Vargas-M´endez and C. M. Mel´endez, Curr. Org. Chem., 2005, 9, 141–161; S. Madapa, Z. Tusi and S. Batra, Curr. Med. Chem., 2008, 12, 1116–1183.spa
dc.relation.referencesS. Madapa, Z. Tusi and S. Batra, Curr. Med. Chem., 2008, 12, 1116–1183.spa
dc.relation.referencesA. Marella, O. P. Tanwar, R. Saha, M. R. Ali, S. Srivastava, M. Akhter, S. Srivastava, M. Akhter, M. Shaquiquzzaman and M. M. Alam, Saudi Pharm. J., 2013, 21, 1–12.spa
dc.relation.referencesS. M. Prajapati, K. D. Patel, R. H. Vekariya, S. N. Panchal and H. D. Patel, RSC Adv., 2014, 4, 24463–24476.spa
dc.relation.referencesJ. B. Bharate, R. A. Vishwakarma and S. B. Bharat, RSC Adv., 2015, 5, 42020–42053.spa
dc.relation.referencesG. A. Ramann and B. J. Cowen, Molecules, 2016, 21, 986– 1009.spa
dc.relation.referencesK. Stuart, R. Brun, S. L. Cro, A. Fairlamb, R. E. Gurtler, ¨ J. McKerrow, S. Reed and R. Tarleton, J. Clin. Invest., 2008, 118, 1301–1310.spa
dc.relation.referencesE. Castillo, M. A. Dea-Ayuela, F. Bol´as-Fern´andez, M. Rangel and M. E. Gonz´alez-Rosende, Curr. Med. Chem., 2010, 17, 4027–4051.spa
dc.relation.referencesA. Cavalli, F. Lizzi, S. Bongarzone, F. Belluti, L. Piazzi and M. L. Bolognesi, FEMS Immunol. Med. Microbiol., 2010, 58, 51–60.spa
dc.relation.referencesL. S. Bernardes, C. L. Zani and I. Carvalho, Curr. Med. Chem., 2013, 20, 2673–2696.spa
dc.relation.referencesA. S. Nagle, S. Khare, A. B. Kumar, F. Supek, A. Buchynskyy, C. J. Mathison, N. K. Chennamaneni, N. Pendem, F. S. Buckner, M. H. Gelb and V. Molteni, Chem. Rev., 2014, 114, 11305–11347.spa
dc.relation.referencesM. C. Field, D. Horn, A. H. Fairlamb, M. A. Ferguson, D. W. Gray, K. D. Read, M. De Rycker, L. S. Torrie, P. G. Wyatt, S. Wyllie and I. H. Gilbert, Nat. Rev. Microbiol., 2017, 15, 217–231.spa
dc.relation.referencesB. Zulqar, T. B. Shelper and V. M. Aver, Drug Discovery Today, 2017, 22, 1516–1531.spa
dc.relation.referencesM. P. Barrett and S. L. Cro, Br. Med. Bull., 2012, 104, 175– 196.spa
dc.relation.referencesC. Bern, Chagas' Disease, N. Engl. J. Med., 2015, 373, 456– 466.spa
dc.relation.referencesM. T. Scotti, L. Scotti, H. Ishiki, F. F. Ribeiro, R. M. Duarte da Cruz, M. P. de Oliveira and F. J. B. Mendonça, Comb. Chem. High Throughput Screen., 2016, 19, 537–553.spa
dc.relation.referencesM. Willcox, Planta Med., 2011, 77, 662–671.spa
dc.relation.referencesV. V. Kouznetsov and A. G´omez-Barrio, Eur. J. Med. Chem., 2009, 44, 3091–3113.spa
dc.relation.referencesV. V. Kouznetsov, New Quinoline-Based Multiple Ligands in Antimalarial Drug Development in: Antimalarial Drug Research and Development, ed. A. C. Banet and P. E. Brassier, Nova Biomedica, New York, 2013, ch. II, pp. 69– 128.spa
dc.relation.referencesS. Hoet, F. Opperdoes, R. Brun and J. Quetin-Leclercq, Nat. Prod. Rep., 2004, 21, 353–364.spa
dc.relation.referencesM. J. Chan-Bacab and L. M. Pena-Rodriguez, Nat. Prod. Rep., 2001, 18, 674–688.spa
dc.relation.referencesX. Ma, C. Tan, D. Zhu, D. R. Gang and P. Xiao, J. Ethnopharmacol., 2007, 113, 15–34.spa
dc.relation.referencesA. J. Oluwafemi, E. O. Okanla, P. Camps, D. Munoz- ˜ Torrerob, Z. B. Mackey, P. K. Chiang, S. Seville and C. W. Wright, Nat. Prod. Commun., 2009, 4, 193–198.spa
dc.relation.referencesA. Fournet, R. Hocquemiller, F. Roblot, A. Cav´e, P. Richomme and J. Bruneton, J. Nat. Prod., 1993, 56, 1547–1552.spa
dc.relation.referencesA. Fournet, M. E. Ferreira, A. Rojas de Arias, S. Torres de Ortiz, S. Fuentes, H. Nakayama, A. Schinini and R. Hocquemiller, Antimicrob. Agents Chemother., 1996, 40, 2447–2451.spa
dc.relation.referencesK. A. Reynolds, W. A. Loughlin and D. J. Young, Mini-Rev. Med. Chem., 2013, 13, 730–743.spa
dc.relation.referencesF. Zongo, C. Ribuot, A. Boumendjel and I. Guissou, J. Ethnopharmacol., 2013, 148, 14–26.spa
dc.relation.referencesS. Cretton, L. Breant, L. Pourrez, C. Ambuehl, L. Marcourt, S. N. Ebrahimi, M. Hamburger, R. Perozzo, S. Karimou, M. Kaiser, M. Muriel and M. Cuendet, J. Nat. Prod., 2014, 77, 2304–2311.spa
dc.relation.referencesJ. L. Tucker, Org. Process Res. Dev., 2006, 10, 315–319.spa
dc.relation.referencesV. F. Batista, D. C. Pinto and A. Silva A, ACS Sustain. Chem. Eng., 2016, 4, 4064–4078.spa
dc.relation.referencesM. A. Fakhfakh, X. Franck, A. Fournet, R. Hocquemiller and B. Figad`ere, Tetrahedron Lett., 2001, 42, 3847–3850.spa
dc.relation.referencesM. A. Fakhfakh, A. Fournet, E. Prina, J. F. Mouscadet, X. Franck, R. Hocquemiller and B. Figad`ere, Bioorg. Med. Chem., 2003, 11, 5013–5023.spa
dc.relation.referencesN. Campos-Vieira, C. Herrenknecht, J. Vacus, A. Fournet, C. Bories, B. Figad`ere, L. S. Espindola and P. M. Loiseau, Biomed. Pharmacother., 2008, 62, 684–689.spa
dc.relation.referencesA. Fournet, A. A. Barrios, V. Munoz, R. Hocquemiller, ˜ F. Roblot, J. Bruneton, P. Richomme and J. C. Gantier, US Patent no. 5541196, 1996.spa
dc.relation.referencesH. Nakayama, P. M. Loiseau, C. Bories, S. T. de Ortiz, A. Schinini, E. Serna, A. R. de Arias, M. A. Fakhfakh, X. Franck, B. Figad`ere, R. Hocquemiller and A. Fournet, Antimicrob. Agents Chemother., 2005, 49, 4950–4956.spa
dc.relation.referencesS. A. Yamashkin and E. A. Oreshkina, Chem. Heterocycl. Compd., 2006, 42, 701–718.spa
dc.relation.referencesV. V. Kouznetsov, Tetrahedron, 2009, 65, 2721–2750.spa
dc.relation.referencesP. Shah, D. Naik, N. Jariwala, D. Bhadane, S. Kumar, S. Kulkarni, K. K. Bhutani and I. P. Singh, Bioorg. Chem., 2018, 80, 591–601.spa
dc.relation.referencesH. Nakayama, J. Desrivot, C. Bories, X. Franck, B. Figadere, R. Hocquemiller, A. Fourn`et and P. M. Loiseau, Biomed. Pharmacother., 2007, 61, 186–188.spa
dc.relation.referencesN. Campos-Vieira, J. Vacus, A. Fournet, R. Baudouin, C. Bories, B. S´eon-M´eniel, B. Figadere and P. M. Loiseau, Parasite, 2011, 18, 333–336.spa
dc.relation.referencesK. Balaraman, N. Campos-Vieira, F. Moussa, J. Vacus, S. Cojean, S. Pomel, C. Bories, B. Figad`ere, V. Kesavane and P. M. Loiseau, Biomed. Pharmacother., 2015, 76, 127– 133.spa
dc.relation.referencesM. A. Fakhfakh, X. Franck, A. Fournet, R. Hocquemiller and B. Figadere, Synth. Commun., 2002, 32, 2863–2875.spa
dc.relation.referencesM. Mart´ınez-Grueiro, C. Gim´enez-Pardo, A. G´omez-Barrio, X. Franck, A. Fournet, R. Hocquemiller, A. Fournet, R. Hocquemiller and B. Figad`ere, Il Farmaco, 2005, 60, 219–224.spa
dc.relation.referencesH. Saggadi, D. Luart, N. Thiebault, I. Polaert, L. Estel and C. Len, Catal. Commun., 2014, 44, 15–18.spa
dc.relation.referencesJ. Jin, S. Guidi, Z. Abada, Z. Amara, M. Selva, M. W. George, M. Poliakoff and T. McInally, Green Chem., 2017, 19, 2439– 2447.spa
dc.relation.referencesA. S. Amarasekara and M. A. Hasan, Tetrahedron Lett., 2014, 55, 3319–3321.spa
dc.relation.referencesA. Li, C. Huang, C. W. Luo, L. J. Li, W. J. Yi, T. W. Liu and Z. S. Chao, Catal. Commun., 2017, 98, 13–16.spa
dc.relation.referencesJ. Safari, H. S. Banitaba and S. S. Samiei, J. Chem. Sci., 2009, 121, 481–484.spa
dc.relation.referencesY. Matsubara, S. Hirakawa, Y. Yamaguchi and Z. I. Yoshida, Angew. Chem., Int. Ed., 2011, 50, 7670–7673.spa
dc.relation.referencesK. K. Chandrashekarappa, K. M. Mahadevan and K. B. Manjappa, Tetrahedron Lett., 2013, 54, 1368–1370.spa
dc.relation.referencesS. T. Le, C. Yasuoka, H. Asahara and N. Nishiwaki, Molecules, 2016, 21, 827–838.spa
dc.relation.referencesY. Ogata, A. Kawasaki and H. Hirata, J. Chem. Soc., Perkin Trans. 2, 1972, 1120–1124.spa
dc.relation.referencesK. Mekouar, J. F. Mouscadet, D. Desma¨ele, F. Subra, H. Leh, D. Savour´e, C. Auclai and J. d'Angelo, J. Med. Chem., 1998, 41, 2846–2857.spa
dc.relation.referencesV. V. Kouznetsov, C. M. Mel´endez G´omez, M. G. Derita, L. Svetaz, E. Del Olmo and S. A. Zacchino, Bioorg. Med. Chem., 2012, 20, 6506–6512.spa
dc.relation.referencesV. Sridharan, C. Avendano and J. C. Men´endez, Tetrahedron, 2009, 65, 2087–2096.spa
dc.relation.referencesP. M. Loiseau, S. Gupta, A. Verma, S. Srivastava, S. K. Puri, F. Sliman, M. Normand-Bayle and D. Desmaele, Antimicrob. Agents Chemother., 2011, 55, 1777–1780.spa
dc.relation.referencesD. E. Pearson, R. D. Wysong and C. V Breder, J. Org. Chem., 1967, 32, 2358–2360.spa
dc.relation.referencesF. Tr´ecourt, M. Mallet, F. Mongin and G. Qu´eguiner, Synthesis, 1995, 1159–1162.spa
dc.relation.referencesM. Normand-Bayle, C. B´enard, F. Zouhiri, J. F. Mouscadet, H. Leh, C. M. Thomas, G. Mbemba, D. Desma¨ele and J. d'Angelo, Bioorg. Med. Chem. Lett., 2005, 15, 4019–4022.spa
dc.relation.referencesE. C. Taylor and S. F. Martin, J. Am. Chem. Soc., 1972, 94, 2874–2875.spa
dc.relation.referencesR. Musiol, B. Podeszwa, J. Finster, H. Niedbala and J. Polanski, Monatsh. Chem., 2006, 137, 1211–1217.spa
dc.relation.referencesJ. Polanski, H. Niedba ´ ła, R. Musioł, D. Tabak, B. Podeszwa, R. Gieleciak, A. Bak, A. Palka and T. Magdziarz, Acta Pol. Pharm., 2004, 61, 3–4.spa
dc.relation.referencesT. N. Gavrishova, V. M. Lee, K. V. Gor’kov and M. F. Budyka, Russ. J. Appl. Chem., 2011, 84, 507–509.spa
dc.relation.referencesE. N. Gulakova, A. G. Sitin, L. G. Kuz’mina and O. A. Fedorova, Russ. J. Org. Chem., 2011, 47, 245–252.spa
dc.relation.referencesW. Cieslik, R. Musiol, J. E. Nycz, J. Jampilek, M. Vejsova, M. Wolff, B. Machura and J. Polanski, Bioorg. Med. Chem., 2012, 20, 6960–6968.spa
dc.relation.referencesM. Staderini, N. Cabezas, M. L. Bolognesi and J. Men´endez, Synlett, 2011, 2577–2579.spa
dc.relation.referencesD. Mao, G. Hong, S. Wu, X. Liu, J. Yu and L. Wang, Eur. J. Org. Chem., 2014, 3009–3019.spa
dc.relation.referencesZ. Jamal, Y. C. Teo and G. S. Lim, Tetrahedron, 2016, 72, 2132–2138.spa
dc.relation.referencesZ. Jamal and Y. C. Teo, Synlett, 2014, 25, 2049–2053.spa
dc.relation.referencesS. Yaragorla, G. Singh and R. Dada, Tetrahedron Lett., 2015, 56, 5924–5929.spa
dc.relation.referencesV. M. Li, T. N. Gavrishova and M. F. Budyka, Russ. J. Org. Chem., 2012, 48, 823–828.spa
dc.relation.referencesL. Xu, Z. Shao, L. Wang, H. Zhao and J. Xiao, Tetrahedron Lett., 2014, 55, 6856–6860.spa
dc.relation.referencesN. N. Rao and H. M. Meshram, Tetrahedron Lett., 2013, 54, 5087–5090.spa
dc.relation.referencesZ. L. Wang, RSC Adv., 2015, 5, 5563–5566.spa
dc.relation.referencesX. Y. Zhang, D. Q. Dong, T. Yue, S. H. Hao and Z. L. Wang, Tetrahedron Lett., 2014, 55, 5462–5464.spa
dc.relation.referencesB. Qian, P. Xie, Y. Xie and H. Huang, Org. Lett., 2011, 13, 2580–2583.spa
dc.relation.referencesY. Yan, K. Xu, Y. Fang and Z. A. Wang, J. Org. Chem., 2011, 76, 6849–6855.spa
dc.relation.referencesB. Bachowska and G. Matusiak, Chem. Heterocycl. Compd., 2009, 45, 80–84.spa
dc.relation.referencesY. G. Zhang, J. K. Xu, X. M. Li and S. K. Tian, Eur. J. Org. Chem., 2013, 3648–3652.spa
dc.relation.referencesY. Li, F. Guo, Z. Zha and Z. Wang, Chem.–Asian J., 2013, 8, 534–537.spa
dc.relation.referencesL. Gong, L. J. Xing, T. Xu, X. P. Zhu, W. Zhou, N. Kang and B. Wang, Org. Biomol. Chem., 2014, 12, 6557–6560.spa
dc.relation.referencesR. Cinar, J. Nordmann, E. Dirksen and T. J. Muller, ¨ Org. Biomol. Chem., 2013, 11, 2597–2604.spa
dc.relation.referencesM. Rams-Baron, M. Dulski, A. Mrozek-Wilczkiewicz, M. Korzec, W. Cieslik, E. Spaczynska, P. Bartczak, ´ A. Ratuszna, J. Polanski and R. Musiol, PLoS One, 2015, 10, e0131210.spa
dc.relation.referencesA. Mrozek-Wilczkiewicz, E. Spaczynska, K. Malarz, W. Cieslik, M. Rams-Baron, V. Kryˇstof and R. Musiol, PLoS One, 2015, 10, e0142678.spa
dc.relation.referencesM. A. A. El-Sayed, W. M. El-Husseiny, N. I. Abdel-Aziz, A. S. El-Azab, H. A. Abuelizz and A. A. M. Abdel-Aziz, J. Enzyme Inhib. Med. Chem., 2018, 33, 199–209.spa
dc.relation.referencesD. Kumar, A. Kumar, M. M. Qadri, M. I. Ansari, A. Gautam and A. K. Chakraborti, RSC Adv., 2015, 5, 2920–2927.spa
dc.relation.referencesM. Dabiri, P. Salehi, M. Baghbanzadeh and M. S. Nikcheh, Tetrahedron Lett., 2008, 49, 5366–5368.spa
dc.relation.referencesP. Sarma, S. Saikia and R. Borah, Synth. Commun., 2016, 46, 1187–1196.spa
dc.relation.referencesS. Yaragorla and P. V. Babu, Tetrahedron Lett., 2017, 58, 1879–1882.spa
dc.relation.referencesM. F. Baig, S. P. Shaik, V. L. Nayak, A. Alari and A. Kamal, Bioorg. Med. Chem. Lett., 2017, 27, 4039–4043.spa
dc.relation.referencesF. Xiao, D. Wang, G. J. Deng and F. A. Zhang, Org. Biomol. Chem., 2019, 17, 9163–9168.spa
dc.relation.referencesZ. Zhang, C. Pi, H. Tong, X. Cui and Y. Wu, Org. Lett., 2017, 19, 440–443.spa
dc.relation.referencesL. Bering and A. P. Antonchick, Org. Lett., 2015, 17, 3134– 3137.spa
dc.relation.referencesJ. Wu, X. Cui, L. Chen, G. Jiang and Y. Wu, J. Am. Chem. Soc., 2009, 131, 13888–13889.spa
dc.relation.referencesH. Xia, Y. Liu, P. Zhao, S. Gou and J. Wang, Org. Lett., 2016, 18, 1796–1799.spa
dc.relation.referencesG. Yan, A. J. Borah and M. Yang, Adv. Synth. Catal., 2014, 356, 2375–2394.spa
dc.relation.referencesS. L. Khillare, M. K. Lande, N. S. Shinde and B. R. Arbad, Der Pharma Chem., 2017, 9, 30–36.spa
dc.relation.referencesX. Wang, X. Xie, Y. Cai, X. Yang, J. Li, Y. Li, W. Chen and M. He, Molecules, 2016, 21, 340–351.spa
dc.relation.referencesB. Mir and S. S. Samiei, J. Chem. Chem. Eng., 2011, 5, 644– 647.spa
dc.relation.referencesD. Shahabi and H. Tavakol, J. Mol. Liq., 2016, 220, 324–328.spa
dc.relation.referencesS. Anvar, I. Mohammadpoor-Baltork, S. Tangestaninejad, M. Moghadam, V. Mirkhani, A. R. Khosropour, A. L. Isfahani and R. Kia, ACS Comb. Sci., 2014, 16, 93–100.spa
dc.relation.referencesX. F. Lin, S. L. Cui and Y. G. Wang, Tetrahedron Lett., 2006, 47, 3127–3130.spa
dc.relation.referencesP. J. Stevenson, P. He and B. Daly, Tetrahedron, 2014, 70, 7350–7357.spa
dc.relation.referencesS. Mahat, A. Mukherjee, S. Santra, G. V. Zyryanov and A. Majee, Org. Biomol. Chem., 2019, 17, 7907–7917.spa
dc.relation.referencesY. Li, X. Cao, Y. Liu and J. P. Wan, Org. Biomol. Chem., 2017, 15, 9585–9589.spa
dc.relation.referencesX. Gen, X. Wu, P. Zhao, J. Zhang, Y. D. Wu and A. X. Wu, Org. Lett., 2017, 19, 4179–4182.spa
dc.relation.referencesR. S. Upadhayaya, S. S. Dixit, A. F¨oldesi and J. Chattopadhyaya, Bioorg. Med. Chem. Lett., 2013, 23, 2750–2758.spa
dc.relation.referencesC. E Brown, J. McNulty, C. Bord´on, R. Yolken and L. JonesBrando, Org. Biomol. Chem., 2016, 14, 5951–5955.spa
dc.relation.referencesD. Bompart, J. Nu´nez-Dur ˜ ´an, D. Rodr´ıguez, V. V. Kouznetsov, C. M. Mel´endez, F. Sojo, F. Arvelo, G. Visbal, A. Alvarez, X. Serrano-Mart´ın and Y. Garc´ıaMarch´an, Bioorg. Med. Chem. Lett., 2013, 21, 4426–4431.spa
dc.relation.referencesV. V. Kouznetsov, L. Y. Vargas, S. Milena, U. Mora Cruz, C. A. Coronado, C. M. Mel´endez, A. R. Romero and P. Escobar Rivero, Lett. Drug Des. Discov., 2007, 4, 293–296.spa
dc.relation.referencesA. S. G. Nefertiti, M. M. Batista, P. B. Da Silva, D. G. J. Batista, C. F. Da Silva, R. B. Peres, E. C. TorresSantos, E. F. Cunha-Junior, E. Holt, D. W. Boykin, R. Brun, T. Wenzler and M. N. C. Soeiro, Antimicrob. Agents Chemother., 2018, 62, e01936-17.spa
dc.relation.referencesX. S. Wang, J. Zhou, M. Y. Yin, K. Yang and S. J. Tu, J. Comb. Chem., 2010, 12, 266–269.spa
dc.relation.referencesC. R. Borel, L. C. A. Barbosa, C. R. A Maltha and S. A. A ´ Fernandes, Tetrahedron Lett., 2015, 56, 662–665.spa
dc.relation.referencesP. P. Varma, B. Sherigara, K. M. Mahadevan and V. Hulikal, Synth. Commun., 2010, 40, 2220–2231.spa
dc.relation.referencesK. H. Narasimhamurthy, S. Chandrappa, K. S. S Kumar, T. R. Swaroop and K. S. Rangappa, Chem. Lett., 2013, 42, 1073–1075.spa
dc.relation.referencesX. Xu, X. Zhang, W. Liu, Q. Zhao, Z. Wang, L. Yu and F. Shi, Tetrahedron Lett., 2015, 56, 3790–3792.spa
dc.relation.referencesS. Das, S. D. Maiti and S. De Sarkar, J. Org. Chem., 2018, 83, 2309–2316.spa
dc.relation.referencesN. T. Patil and V. S. Raut, J. Org. Chem., 2010, 75, 6961–6964.spa
dc.relation.referencesO. De Paolis, L. Teixeira and B. T¨or¨ok, Tetrahedron Lett., 2009, 50, 2939–2942.spa
dc.relation.referencesZ. Zheng, G. Deng and Y. Liang, RSC Adv., 2016, 6, 103478– 103481.spa
dc.relation.referencesY. Liu, Y. Hu, Z. Cao, X. Zhan, W. Luo, Q. Liu and C. Guo, Adv. Synth. Catal., 2018, 360, 2691–2695.spa
dc.relation.referencesQ. Wang, M. Wang, H. J. Li, S. Zhu, Y. Liu and Y. C. Wu, Synthesis, 2016, 48, 3985–3995.spa
dc.relation.referencesC. Xu, H. M. Li, X. E. Yuan, Z. Q. Xiao, Z. Q. Wang, W. J Fu, B. J. Ji and X. Q. Hao, Org. Biomol. Chem., 2014, 12, 3114– 3122.spa
dc.relation.referencesX. Zhang, X. Xu, L. Yu and Q. Zhao, Tetrahedron Lett., 2014, 55, 2280–2282.spa
dc.relation.referencesS. Y. Lee, J. Jeon and C. H. Cheon, J. Org. Chem., 2018, 83, 5177–5186.spa
dc.relation.referencesS. Y. Lee and C. H. Cheon, J. Org. Chem., 2018, 83, 13036– 13044.spa
dc.relation.referencesX. Ren, S. Han, X. Gao, J. Li, D. Zou, Y. Wu and Y. Wu, Tetrahedron Lett., 2018, 59, 1065–1068.spa
dc.relation.referencesY. Zhang, M. Wang, P. Li and L. Wang, Org. Lett., 2012, 14, 2206–2209.spa
dc.relation.referencesH. Sharghi, M. Aberi, M. Khataminejad and P. Shiri, Beilstein J. Org. Chem., 2017, 13, 1977–1981.spa
dc.relation.referencesP. Zhang, Y. Yang, Z. Chen, Z. Xu, X. Xu, Z. Zhou, X. Yu and W. Yi, Adv. Synth. Catal., 2019, 361, 3002–3007.spa
dc.relation.referencesX. Zhang and X. Xu, Chem.–Asian J., 2014, 9, 3089–3093.spa
dc.relation.referencesX. Xu, Y. Yang, X. Chen, X. Zhang and W. Yi, Org. Biomol. Chem., 2017, 15, 9061–9065.spa
dc.relation.referencesS. D. Jadhav and A. Singh, Org. Lett., 2017, 19, 5673–5676.spa
dc.relation.referencesX. Xu, Y. Yang, X. Zhang and W. Yi, Org. Lett., 2018, 20, 566– 569.spa
dc.relation.referencesM. Phanindrudu, S. B. Wakade, D. K. Tiwari, P. R. Likhar and D. K. Tiwari, J. Org. Chem., 2018, 83, 9137–9143.spa
dc.relation.referencesT. S. Jiang, X. Wang and X. Zhang, Tetrahedron Lett., 2018, 59, 2979–2982.spa
dc.relation.referencesJ. Tummatorn, C. Thongsornkleeb and S. Ruchirawat, Tetrahedron, 2012, 68, 4732–4739.spa
dc.relation.referencesJ. Tummatorn, P. Poonsilp, P. Nimnual, J. Janprasit, C. Thongsornkleeb and S. Ruchirawat, J. Org. Chem., 2015, 80, 4516–4525.spa
dc.relation.referencesC. Z. Luo, P. Gandeepan, Y. C. Wu, W. C. Chen and C. H. Cheng, RSC Adv., 2015, 5, 106012–106018.spa
dc.relation.referencesW. H. Pearson and W. K. Fang, Isr. J. Chem., 1997, 37, 39–46.spa
dc.relation.referencesX. Pang, M. Wu, J. Ni, F. Zhang, J. Lan, B. Chen and R. Yan, J. Org. Chem., 2017, 82, 10110–10120.spa
dc.relation.referencesR. Sharma, P. Kour and A. A. Kumar, J. Chem. Sci., 2018, 130, 73–98.spa
dc.relation.referencesM. Fallah-Mehrjardi, Mini-Rev. Org. Chem., 2017, 14, 187– 196.spa
dc.relation.referencesX. Xu, W. Liu, Z. Wang, Y. Feng, Y. Yan and X. Zhang, Tetrahedron Lett., 2016, 57, 226–229.spa
dc.relation.referencesS. Liu, G. Li and F. Xu, J. Chin. Chem. Soc., 2018, 1–5.spa
dc.relation.referencesX. Zhang and X. Xu, Chem.–Asian J., 2014, 9, 3089–3093.spa
dc.relation.referencesF. Xiao, Y. Chen, Y. Liu and J. Wang, Tetrahedron, 2008, 64, 2755–2761.spa
dc.relation.referencesC. E. Meyet and C. H. Larsen, J. Org. Chem., 2014, 79, 9835– 9841.spa
dc.relation.referencesP. B. Sarode, S. P. Bahekar and H. S. Chandak, Tetrahedron Lett., 2016, 57, 5753–5756.spa
dc.relation.referencesX. Li, Z. Mao, Y. Wang, Y. W. Chen and X. Lin, Tetrahedron, 2011, 67, 3858–3862.spa
dc.relation.referencesV. Fasano, J. E. Radcliffe and M. J. Ingleson, Organometallics, 2017, 36, 1623–1629.spa
dc.relation.referencesY. J. Tan, F. J. Wang, A. M. Asirib, H. M. Marwanib and Z. Zhang, J. Chin. Chem. Soc., 2018, 65, 65–73.spa
dc.relation.referencesF. Zhang, Q. Lai, X. Shi and Z. Song, Chin. Chem. Lett., 2018, 30, 392–394.spa
dc.relation.referencesH. Xu, W. Chen, P. Zhan and X. Liu, MedChemComm, 2015, 6, 61–74.spa
dc.relation.referencesV. Oliveri and G. Vecchio, Eur. J. Med. Chem., 2016, 120, 252–274.spa
dc.relation.referencesM. Albrecht, M. Fiege and O. Osetska, Coord. Chem. Rev., 2008, 252, 812–824.spa
dc.relation.referencesS. Yu, J. Wu, H. Lan, H. Xu, X. Shi, X. Zhu and Z. Yin, RSC Adv., 2018, 8, 33968–33971.spa
dc.relation.referencesK. M. Jiang, J. A. Kang, Y. Jin and J. Lin, Org. Chem. Front., 2018, 5, 434–441.spa
dc.relation.referencesJ. Yang, X. Meng, K. Lu, Z. Lu, M. Huang and C. Wang, RSC Adv., 2018, 8, 31603–31607.spa
dc.relation.referencesM. Zhong, S. Sun, J. Cheng and Y. Shao, J. Org. Chem., 2016, 81, 10825–10831.spa
dc.relation.referencesW. Ahmed, S. Zhang, X. Yu, Y. Yamamoto and M. Bao, Green Chem., 2018, 20, 261–265.spa
dc.relation.referencesP. Gisbert, M. Albert-Soriano and I. M. Pastor, Eur. J. Org Chem., 2019, 4928–4940.spa
dc.relation.referencesP. da Silveira, S. Ligia and T. R. A. Vasconcelos, Mini-Rev. Org. Chem., 2019, 16, 602–608.spa
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.subject.keywordquinolinespa
dc.subject.keywordanti-kinetoplastid agentsspa
dc.subject.keywordChagas diseasespa
dc.titleRecent synthetic efforts in the preparation of 2- (3,4)-alkenyl (aryl) quinoline molecules towards anti-kinetoplastid agentsspa
dc.type.categoryGeneración de Nuevo Conocimiento: Artículos publicados en revistas especializadas - Electrónicosspa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
[email protected]
Tamaño:
3 MB
Formato:
Adobe Portable Document Format
Descripción:

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
807 B
Formato:
Item-specific license agreed upon to submission
Descripción: